112 related articles for article (PubMed ID: 36378891)
1. Association of Liver Function Tests with Mortality in an Insurance Applicant Population.
Rigatti SJ; Stout R
J Insur Med; 2022 Jul; 49(3):172-182. PubMed ID: 36378891
[TBL] [Abstract][Full Text] [Related]
2. Using liver enzymes as screening tests to predict mortality risk.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2008; 40(3-4):191-203. PubMed ID: 19317327
[TBL] [Abstract][Full Text] [Related]
3. Mortality associated with bilirubin levels in insurance applicants.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2009; 41(1):49-53. PubMed ID: 19518005
[TBL] [Abstract][Full Text] [Related]
4. Liver function tests and mortality in a cohort of life insurance applicants.
Pinkham CA; Krause KJ
J Insur Med; 2009; 41(3):170-7. PubMed ID: 20377096
[TBL] [Abstract][Full Text] [Related]
5. 2014 CRL Build Study of Life Insurance Applicants.
Fulks M; Dolan VF; Stout RL
J Insur Med; 2016; 46(1):13-9. PubMed ID: 27562108
[TBL] [Abstract][Full Text] [Related]
6. All-Cause Mortality for Life Insurance Applicants with a History of Prostate Cancer.
Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Beckman M; Rigatti SJ; Gill S
J Insur Med; 2017; 47(2):95-106. PubMed ID: 29490159
[TBL] [Abstract][Full Text] [Related]
7. Association of Carcinoembryonic Antigen with Mortality in an Insurance Applicant Population.
Rigatti SJ; Stout R
J Insur Med; 2019; 48(1):24-35. PubMed ID: 31747325
[No Abstract] [Full Text] [Related]
8. All-Cause Mortality for Life Insurance Applicants with the Presence of Bundle Branch Block.
Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Zamarripa D; Gill S
J Insur Med; 2019; 48(1):36-47. PubMed ID: 31219368
[No Abstract] [Full Text] [Related]
9. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
[TBL] [Abstract][Full Text] [Related]
10. All-Cause Mortality for Life Insurance Applicants with a Family History of Coronary Artery Disease Before 60.
Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Gill S
J Insur Med; 2018 Jan; 47(3):159-171. PubMed ID: 30192720
[TBL] [Abstract][Full Text] [Related]
11. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial.
Ambrosy AP; Vaduganathan M; Huffman MD; Khan S; Kwasny MJ; Fought AJ; Maggioni AP; Swedberg K; Konstam MA; Zannad F; Gheorghiade M;
Eur J Heart Fail; 2012 Mar; 14(3):302-11. PubMed ID: 22357577
[TBL] [Abstract][Full Text] [Related]
12. All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer.
Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Hart A; Rigatti SJ; Gill S
J Insur Med; 2017; 47(1):6-22. PubMed ID: 28836905
[TBL] [Abstract][Full Text] [Related]
13. Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study.
Lilford RJ; Bentham L; Girling A; Litchfield I; Lancashire R; Armstrong D; Jones R; Marteau T; Neuberger J; Gill P; Cramb R; Olliff S; Arnold D; Khan K; Armstrong MJ; Houlihan DD; Newsome PN; Chilton PJ; Moons K; Altman D
Health Technol Assess; 2013 Jul; 17(28):i-xiv, 1-307. PubMed ID: 23834998
[TBL] [Abstract][Full Text] [Related]
14. Serum liver enzymes are associated with all-cause mortality in an elderly population.
Koehler EM; Sanna D; Hansen BE; van Rooij FJ; Heeringa J; Hofman A; Tiemeier H; Stricker BH; Schouten JN; Janssen HL
Liver Int; 2014 Feb; 34(2):296-304. PubMed ID: 24219360
[TBL] [Abstract][Full Text] [Related]
15. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
[TBL] [Abstract][Full Text] [Related]
16. Serum globulin predicts all-cause mortality for life insurance applicants.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
[TBL] [Abstract][Full Text] [Related]
17. Liver function tests: what is the risk?
Titcomb CP
J Insur Med; 2003; 35(1):26-35. PubMed ID: 14694823
[TBL] [Abstract][Full Text] [Related]
18. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study.
Majoni SW; Barzi F; Hoy W; MacIsaac RJ; Cass A; Maple-Brown L; Hughes JT
BMC Nephrol; 2020 Dec; 21(1):523. PubMed ID: 33261565
[TBL] [Abstract][Full Text] [Related]
19. Relationship of hemoglobin A1c to mortality in nonsmoking insurance applicants.
Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
J Insur Med; 2007; 39(3):174-81. PubMed ID: 18251376
[TBL] [Abstract][Full Text] [Related]
20. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
Biegus J; Hillege HL; Postmus D; Valente MA; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Massie BM; Metra M; Teerlink JR; Voors AA; O'Connor CM; Ponikowski P
Eur J Heart Fail; 2016 Jul; 18(7):830-9. PubMed ID: 27170455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
